Hemofarm AD Farmaceutsko-hemijska industrija Vrsac 2020 Sustainability Report
Company: Hemofarm AD Farmaceutsko-hemijska industrija Vrsac
Sector: Manufacturing
Country: Serbia
Year: 2020
Type: Sustainability Report
Pages: 86
The report describes sustaining medicine production and supply during the COVID-19 pandemic, with 278 million packs produced and approximately 2,878 Hemofarm A.D. employees. Sales income grew 11.23% from 2019, while the report states water consumption declined 1.3% despite increased production complexity. It also details employee protections and training, community health support, and GRI-based reporting.
Indicators available in this report: